Doximity, Inc. Files 8-K for Operations Update
Ticker: DOCS · Form: 8-K · Filed: May 16, 2024 · CIK: 1516513
| Field | Detail |
|---|---|
| Company | Doximity, Inc. (DOCS) |
| Form Type | 8-K |
| Filed Date | May 16, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, operations, financial-condition
Related Tickers: DOCS
TL;DR
DOX filed an 8-K, standard ops update, no new numbers yet.
AI Summary
Doximity, Inc. filed an 8-K on May 16, 2024, to report on its financial condition and operations. The filing does not contain specific financial results or forward-looking statements but serves as a notification of ongoing business activities.
Why It Matters
This filing indicates Doximity is providing routine updates on its business operations and financial condition to the SEC, which is important for investors monitoring the company's status.
Risk Assessment
Risk Level: low — This is a routine filing with no new material financial information or significant corporate events disclosed.
Key Players & Entities
- Doximity, Inc. (company) — Registrant
- May 16, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 500 3rd St. Suite 510 San Francisco , CA 94107 (address) — Business Address
FAQ
What is the primary purpose of this 8-K filing for Doximity, Inc.?
The primary purpose of this 8-K filing is to report on Doximity, Inc.'s Results of Operations and Financial Condition, as well as Regulation FD Disclosure.
On what date was this 8-K report filed?
This 8-K report was filed on May 16, 2024.
In which state is Doximity, Inc. incorporated?
Doximity, Inc. is incorporated in Delaware.
What is Doximity, Inc.'s business address?
Doximity, Inc.'s business address is 500 3rd St. Suite 510 San Francisco, CA 94107.
Does this filing contain specific financial results for Doximity, Inc.?
This filing does not appear to contain specific financial results; it is a current report filed as of May 16, 2024, indicating ongoing business activities and financial condition reporting.
Filing Stats: 604 words · 2 min read · ~2 pages · Grade level 9.8 · Accepted 2024-05-16 16:11:08
Key Financial Figures
- $0.001 — which registered Class A common stock, $0.001 par value per share DOCS The New York S
Filing Documents
- docs-20240516.htm (8-K) — 27KB
- doximity-2024331xex991.htm (EX-99.1) — 393KB
- revrecbillingpresentatio.htm (EX-99.2) — 8KB
- revrecbillingpresentatio001.jpg (GRAPHIC) — 144KB
- revrecbillingpresentatio002.jpg (GRAPHIC) — 172KB
- revrecbillingpresentatio003.jpg (GRAPHIC) — 185KB
- revrecbillingpresentatio004.jpg (GRAPHIC) — 106KB
- revrecbillingpresentatio005.jpg (GRAPHIC) — 113KB
- 0001516513-24-000019.txt ( ) — 1572KB
- docs-20240516.xsd (EX-101.SCH) — 2KB
- docs-20240516_lab.xml (EX-101.LAB) — 22KB
- docs-20240516_pre.xml (EX-101.PRE) — 13KB
- docs-20240516_htm.xml (XML) — 3KB
02 – Results of Operations and Financial Condition
Item 2.02 – Results of Operations and Financial Condition On May 16, 2024 , Doximity, Inc. ("Doximity") issued a press release announcing its financial results for its fiscal quarter and year ended March 31, 2024. A copy of the press release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated by reference herein.
01 – Regulation FD Disclosure
Item 7.01 – Regulation FD Disclosure The Company from time to time presents slide presentations to the investment community to provide updates and summaries of its business. The Company is posting a slide presentation to the "Investors" portion of its website at investors.doximity.com/news/presentations/. These slides are attached to this Current Report on Form 8-K as Exhibit 99.2. The information provided in Items 2.02 and 7.01 of this Current Report on Form 8-K, and Exhibits 99.1 and 99.2 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, except as expressly set forth by specific reference in such filing.
01 – Financial Statements and Exhibits
Item 9.01 – Financial Statements and Exhibits (d) Exhibits Exhibit Number Description 99.1 Press Release entitled "Doximity Announces Fourth Quarter and Fiscal Year 2024 Financial Results dated May 16, 2024" 99.2 Revenue Recognition and Billing Presentation, dated May 16, 2024. 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 16, 2024 DOXIMITY, INC. By: /s/ Anna Bryson Anna Bryson Chief Financial Officer